ArticleJournal of ophthalmic inflammation and infection2025
Acute macular neuroretinopathy occurrence in a Behçet disease patient: a case report.
Article in Journal of ophthalmic inflammation and infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo report the occurrence of AMN (Acute Macular Neuroretinopathy) in a Behçet Disease (BD) patient during an active systemic inflammatory relapse and to describe the SD-OCT features of this entity. PATIENTS AND
methodsRetrospective observational case report of a patient who presented with an AMN during a BD associated ocular inflammation (Saint Pierre Hospital, Brussels, Belgium). Clinical record and imaging, including infrared reflectance image (IR) and spectral domain optical coherence tomography (SD-OCT), were analyzed.
resultsA 25-year-old man presented with an acute right eye scotoma due to AMN in the setting of active systemic BD. Oral corticosteroid therapy and corticosteroid sparing agents (azathioprine) were prescribed. Close observation revealed progressive lesion regression.
conclusionIn conclusion, the association between AMN and BD may occur in the context of active systemic disease, though further studies are required to better establish this link. Vigilance appears warranted during inflammatory episodes in BD, as they might contribute to such manifestations. Clinicians could consider BD as a potential differential diagnosis in patients presenting with features suggestive of AMN, and neurological involvement may merit cerebral imaging to exclude other causes. Additionally, the management of posterior uveitis in BD, if present, may benefit from timely and targeted treatment. Further investigations are necessary to refine management strategies for AMN in patients with BD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.